JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

Search

Medpace Holdings Inc

Closed

SectorHealthcare

604.64 1.7

Overview

Share price change

24h

Current

Min

600.29

Max

607.75

Key metrics

By Trading Economics

Income

-24M

90M

Sales

45M

603M

P/E

Sector Avg

40.477

37.461

Profit margin

14.961

Employees

6,000

EBITDA

-2.8M

118M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

-19.99% downside

Market Stats

By TradingEconomics

Market Cap

6.4B

15B

Previous open

602.94

Previous close

604.64

News Sentiment

By Acuity

34%

66%

80 / 371 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

Medpace Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

23 paź 2025, 15:15 UTC

Earnings

Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back -- Barrons.com

Peer Comparison

Price change

Medpace Holdings Inc Forecast

Price Target

By TipRanks

-19.99% downside

12 Months Forecast

Average 484.25 USD  -19.99%

High 655 USD

Low 305 USD

Based on 10 Wall Street analysts offering 12 month price targets forMedpace Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

10 ratings

1

Buy

6

Hold

3

Sell

Technical Score

By Trading Central

300 / 302.88Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Weak Bearish Evidence

Sentiment

By Acuity

80 / 371 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
help-icon Live chat